Home/Filings/4/0000899243-22-036367
4//SEC Filing

Olagunju Peter 4

Accession 0000899243-22-036367

CIK 0001750019other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:22 PM ET

Size

13.8 KB

Accession

0000899243-22-036367

Insider Transaction Report

Form 4
Period: 2022-11-17
Olagunju Peter
Chief Technical Officer
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-11-17254,8470 total
    Exercise: $12.69Exp: 2031-07-25Common Stock (254,847 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-11-1731,5200 total
    Exercise: $12.69Exp: 2031-07-25Common Stock (31,520 underlying)
  • Award

    Restricted Stock Unit (right to buy)

    2022-11-17+84,94984,949 total
    Common Stock (84,949 underlying)
  • Award

    Restricted Stock Unit (right to buy)

    2022-11-17+10,50710,507 total
    Common Stock (10,507 underlying)
Holdings
  • Common Stock

    2,192
Footnotes (5)
  • [F1]This cancelled option vested 25% on July 26, 2022 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
  • [F2]On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on July 26, 2021. In exchange for such stock option, the reporting person received restricted stock units in the amount of 10,507.
  • [F3]Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
  • [F4]35% of these RSUs will vest December 1, 2022, 25% of these RSUs will vest on each of December 1, 2023 and December 1, 2024, and the remaining 15% of RSUs will vest on December 1, 2025.
  • [F5]On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on July 26, 2021. In exchange for such stock option, the reporting person received restricted stock units in the amount of 84,949.

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

Entity typeother

Related Parties

1
  • filerCIK 0001875057

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:22 PM ET
Size
13.8 KB